Publications by authors named "Ingrid A Cox"

Claim this Profile
U
Unravelling the health and economic burden of interstitial lung diseases in adults in Australia.
Ingrid A Cox, Barbara de Graaff, Qiang Zheng, Tamera J Corte, E Haydn Walters

Aust J Gen Pract· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing health state utilities for people with myalgic encephalomyelitis/chronic fatigue syndrome in Australia using the EQ-5D-5L, AQoL-8D and EQ-5D-5L-psychosocial instruments.
Nneka C Orji, Ingrid A Cox, Leonard A Jason, Gang Chen, Ting Zhao

Qual Life Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden of myalgic encephalomyelitis/chronic fatigue syndrome in Australia.
Ting Zhao, Ingrid A Cox, Hasnat Ahmad, Julie A Campbell, Martin Hensher

Aust Health Rev· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from Australia.
Qiang Zheng, Ingrid A Cox, Lucy Leigh, Barbara de Graaff, Fay H Johnston

Respirology· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular and health cost impacts of cuff blood pressure underestimation and overestimation of invasive aortic systolic blood pressure.
Ricardo Fonseca, Andrew J Palmer, Dean S Picone, Ingrid A Cox, Martin G Schultz

J Hypertens· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study.
Ingrid A Cox, Barbara de Graaff, Hasnat Ahmed, Julie Campbell, Petr Otahal

Eur J Health Econ· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument.
Qiang Zheng, Ingrid A Cox, Barbara de Graaff, Julie A Campbell, Tamera J Corte

Qual Life Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease.
Alyson W Wong, Huiying Sun, Ingrid A Cox, Jolene H Fisher, Nasreen Khalil

PLoS One· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study.
Qiang Zheng, Petr Otahal, Ingrid A Cox, Barbara de Graaff, Julie A Campbell

Front Med (Lausanne)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D.
Ingrid A Cox, Julie Campbell, Barbara de Graaff, Petr Otahal, Tamera J Corte

Qual Life Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comprehensive Systematic Review of Data Linkage Publications on Diabetes in Australia.
Ngan T T Dinh, Ingrid A Cox, Barbara de Graaff, Julie A Campbell, Brian Stokes

Front Public Health· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia.
Ingrid A Cox, Petr Otahal, Barbara de Graaff, Tamera J Corte, Yuben Moodley

Respirology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Qiang Zheng, Ingrid A Cox, Julie A Campbell, Qing Xia, Petr Otahal

ERJ Open Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent trends in pirfenidone and nintedanib use for idiopathic pulmonary fibrosis in Australia.
Ingrid A Cox, Barbara de Graaff, Tamera J Corte, Ian Glaspole, Daniel C Chambers

Aust Health Rev· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia.
Ingrid A Cox, Barbara de Graaff, Hasnat Ahmed, Julie Campbell, Petr Otahal

Qual Life Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Ingrid A Cox, Nicolas Borchers Arriagada, Barbara de Graaff, Tamera J Corte, Ian Glaspole

Eur Respir Rev· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis